MedPath

THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG RATHA AZHUTHA NIVARANI CHOORANAM IN PATIENTS HAVING HIGH BLOOD PRESSURE

Phase 2
Not yet recruiting
Conditions
Hypertensive diseases,
Registration Number
CTRI/2019/02/017577
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE
Brief Summary

THIS IS SINGLE NON-RANDOMIZED OPEN CLINICAL TRIAL TO STUDY THE SAFETY AND EFFICACY OF SIDDHA TRIAL DRUG RATHA AZHUTHA NIVARANI CHOORANAM. THE TRIAL DRUG IS GIVEN 1gm TWICE A DAY ALONG WITH HONEY AS A ADJUVENT FOR 48 DAYS.CLINICAL TRIAL IS CONDUCTED AFTER CONDUCTING PRECLINICAL TOXICITY STUDY.THE TRIAL DRUG RATHA AZHUTHA NIVARANI CHOORANAM IS MENTIONED IN THE PHARMACOPOEIA OF SIDDHA RESEARCH MEDICINES. DURING THE TRIAL  ALL THE STUDY RELATED DATA WILL BE RECORDED AND DOCUMENTED. AFTER THE COMPLETION OF TRIAL ALL THE DATA WILL BE ANALYSED STATISTICALLY.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

BLOOD PRESSURE LEVEL ABOVE 140/90mmHg AND BELOW 180/100mmHg FATIGUE HEADACHE NAUSEA GIDDINESS SWEATING OBESITY.

Exclusion Criteria

BLOOD PRESSURE LEVEL ABOVE 180/100mmHg HYPERTENSION IN PREGNANCY ASSOCIATED OTHER SECONDARY DISEASES LIKE RENAL FAILURE CCF OTHER CARDIAC PROBLEMS CHRONIC DISEASES HORMONAL DISORDERS DIABETES MELLITUS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is mainly assessed by decrease in BP to optimum levelOutcome is mainly assessed by decrease in BP to optimum level
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Arignar Anna Government Hospital for Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Government Hospital for Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
DR THAMIL OVIAM R
Principal investigator
7200665114
ovimithran@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.